INTRODUCTION
In addition, the presence of major histocompatibility complex (MHC) class IIrestricted, Id-specific CD4 + T cells and MHC class I-restricted Id-specific CD8 + T cells has been reported in unimmunized patients with MGUS or MM (8) . These results indicate that these naturally occurring T cells are unable to suppress or eradicate myeloma cells in vivo due to inadequate numbers and functional suppression (9) .
Although more recent studies have demonstrated that Id-specific CD8 + CTLs, which were generated by using Id-pulsed dendritic cells (DCs) were able to lyse primary myeloma cells from patients (10, 11) , it is still unclear whether other types of Id-specific T cells, such as CD4 + Th1 and Th2 cells, are able to suppress or kill myeloma tumor cells. As Id-based immunotherapy may activate all T-cell subsets in patients (4) , it is important to understand the functions of these T cells in the context of myeloma cells.
In this study, we used the 5TGM1 myeloma murine model originally derived from 5T33 myeloma cells (12) (13) (14) , to generate Id-specific T-cell subsets in C57BL/KaLwRij mice and explored the functional roles and anti-myeloma immune responses of Id-specific T-cell subsets on the myeloma tumor cells in vitro and in vivo.
MATERIALS AND METHODS

Mice and cell lines
Male C57BL/KaLwRij mice were purchased from Harlan CPB (Zeist, The Netherland). This study was approved by the Institutional Animal Care and Use Committee of the University of Texas, M. D. Anderson Cancer Center.
The 5TGM1 murine myeloma cell line was cultured in Iscove's modified dulbecco's media (IMDM; Invitrogen, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA), 100 U/mL penicillin-streptomycin, and 2 mM L-glutamine (both from Invitrogen). The B16 melanoma cell line, originated from C57BL/6 mice, was purchased from American Type Culture Collection (ATCC; Rockville, MD) and cultured in IMDM.
Preparation of idiotype protein
The 5TGM1 myeloma cells were cultured in AIM-V serum-free medium and mouse IgG2b Id protein, secreted by the 5TGM1 myeloma cells, was purified from cell culture supernatant using Hi-Trap Protein A affinity chromatography (GE Healthcare, Piscataway, NJ) as described previously (15) . Id protein and keyhole limpet hemocyanin (KLH; EMD Biosciences, La Jolla, CA) conjugate was made using 0.1% glutaraldehyde (Sigma, St. Louis, MO) as described previously (16) to enhance the immunogenicity of the Id protein.
Generation of dendritic cells
DCs were generated from bone marrow stem cells of mice as described previously (17, 18) . Briefly, bone marrow mononuclear cells were cultured at a density of 2 × 10 5 cells/mL in RPMI-1640 complete medium with 20 ng/mL granulocyte-monocyte colony-stimulating factor (GM-CSF; R&D Systems, Minneapolis, MN) at 37°C in 5% CO 2 . At day 4, medium was replaced with fresh medium containing GM-CSF (10 ng/mL), and at day 8, immature DCs were pulsed for 8 hours with Id-KLH proteins at a concentration of 50 μg/mL, followed by addition of tumor necrosis factor (TNF)-α (10 ng/mL) and IL-1β (10 ng/mL; both from R&D Systems) for 48 hours to induce DC maturation.
Mature DCs were collected and used to immunize mice.
Generation of idiotype-specific T-cell clones
Mice were immunized by three weekly subcutaneous injections of Id-KLHpulsed mature DCs (10 6 DCs/injection/mouse). Following each immunization, GM-CSF (200 ng/day) was injected subcutaneously adjacent to the immunization sites for three consecutive days (4) . One week after the 
Detection of cytokine production
Enzyme-linked immunoabsorbent assay (ELISA) was used to measure secreted cytokines such as IFN-γ, TNF-α, IL-2, IL-4, or IL-5 from T-cell clones. T-cell clones were incubated with irradiated (30 Gy) mature DCs pulsed with Id or irrelevant IgG2b protein and unpulsed DCs were used as control. Supernatants were collected, and the amounts of cytokines were quantified using commercially available ELISA kits (R&D Systems).
Proliferation assay
T-cell clones (5 × 10 4 /100 μL/well) were seeded into 96-well U-bottom culture plates. Various numbers of irradiated (30 Gy) mature DCs pulsed with Id or irrelevant mouse IgG2b protein were added and cultured for 4 days at 37°C in 5% CO 2 . Cells were pulsed with 0.5 μCi/well 3 [H]-thymidine (GE Healthcares) and harvested 18 hours later. Radioactivity was measured using a β-liquid scintillation analyzer. Unpulsed DCs were used as control.
Results are shown as mean count per minute (CPM).
In some experiments, T-cell clones were pre-labeled with 5(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE; Invitrogen) for 10 minutes at 37°C. After washing, labeled T-cell clones were seeded and cocultured with irradiated mature DCs pulsed with Id or irrelevant mouse IgG2b protein for 5 days. Unpulsed DCs were used as control. After that, cells were incubated with PE-conjugated CD8 or CD4 mAb for 30 minutes, washed, and ready for analysis.
Cytotoxicity assay
The standard 51 Cr-release assay was performed to measure the cytotoxicity of the T-cell clones against 5TGM1 myeloma cells or DCs pulsed with Id protein as described previously (19) . B16 melanoma cells or unpulsed DCs were used as control target cells. CD8 + or CD4 + T cells purified from spleens of naïve mice using anti-CD8 or CD4 mAb-coated magnetic beads (Miltenyi Biotec, Auburn, CA) were used as controls for effectors cells. Target cells were labeled with 51 Cr-sodium chromate (GE Healthcares) for one hour and incubated with various numbers of T cells in 96-well U-bottom culture plates.
After 4 hours, 50% of the supernatants were collected, and radioactivity was measured by a gamma-counter. Results are shown as mean percentage 51 Cr release calculated as follows: [(sample counts − spontaneous counts)/ (maximum counts − spontaneous counts)] × 100.
In some experiments, 5TGM1 myeloma cells were pre-labeled with PKH26 red fluorescent using cell linker kits (Sigma) and co-cultured with T-cell clones. 5TGM1 myeloma cells cultured without T cells were used as negative control. CD8 + or CD4 + T cells isolated from splenocytes of naïve mice served as controls for effector T cells. After 18 hours, FITC-conjugated Annexin-V (BD Biosciences) was added to the cells, incubated for 15 minutes, and analyzed using a flow cytometer.
Inhibition of T cell-mediated cytotoxicity
To determine whether the cytotoxic activity of the T cells was restricted or mediated by MHC molecules, perforin, or FasL, mAbs against MHC class I, II, or FasL were used to block the cytotoxicity of the T-cell clones against 5TGM1 myeloma cells. CTL or Th1 clones were co-cultured with 5TGM1 myeloma cells in the presence or absence of 20 μg/mL mAbs against MHC class I or II (both from BD Biosciences) or FasL (R&D Systems). Isotypic control IgG (Jackson ImmunoResearch, West Grove, PA) was used as control. In addition, concanamycin A (CMA; Sigma), an inhibitor of vacuolar type H + -ATPase, was used as selective inhibitor of perforin-mediated cytotoxicity (20) . Effector T-cell clones were pretreated with 100 nM of CMA for 2 hours and assayed for cytotoxicity in the presence of the reagent.
T-cell inhibition assay
The suppressive activity of T-cell clones on myeloma cell growth and secretion of Id protein or cytokines such as vascular endothelial growth factor (VEGF) was performed by using 3 [H]-thymidine incorporation and ELISA assays. 5TGM1 myeloma cells were seeded at a density of 1 × 10 4 /100 μL/well into 96-well U-bottom tissue culture plates. Irradiated (30 Gy) T-cell clones were added at a density of 5 × 10 4 /100 μL/well to the plates and co-cultured with the myeloma cells for 3 days at 37°C in 5% CO 2 . Cells were pulsed with 0.5 μCi/well 3 [H]-thymidine and harvested 18 hours later.
Radioactivity was measured using a β-liquid scintillation analyzer.
In some experiments, supernatants from T-cell clones co-cultured with 5TGM1 myeloma cells were collected. Secreted IgG2b Id protein or VEGF from 5TGM1 myeloma cells were measured by ELISA assay as described previously (21) .
In vivo adoptive transfer of T-cell clones
Mice were challenged intravenously with 2 × 10 6 5TGM1 myeloma cells. One week later when myeloma growth was established, 2 × 10 6 T-cell clones were injected intravenously into tumor-bearing mice. Control mice received an injection of PBS or the same number of splenocytes from naïve mice. 
Statistical analysis
Student's t-test was used to compare various experimental groups. P < 0.05 was considered statistically significant. Survival was evaluated from the day of tumor injection until death, and Kaplan-Meier test used to compare mouse survival between the groups. All data are shown as mean and SD.
RESULTS
Generation of idiotype-specific T-cell clones
To obtain Id-specific T-cell clones, immature DCs generated from C57BL/KaLwRij mouse bone marrow stem cells were pulsed with purified Id-KLH conjugate, matured with TNF-α and IL-1β, and injected into mice. One week after the third immunization, mice were sacrificed, and splenocytes were restimulated in vitro with Id protein for one week. Using limiting dilution assay, we generated Id-specific T-cell clones that secreted high levels of IFN-γ or IL-4 ( 
Proliferative responses of the T-cell clones
To examine the functional properties of these T-cell clones, we first examined T-cell proliferative response induced by Id protein using 3 [H]-thymidine incorporation assay. Findings from clones 2, 8, and 16 are shown as representative results in the following studies. As shown in Fig. 2A , all of the T-cell clones significantly proliferated in response to syngeneic DCs pulsed with Id protein (P < 0.01, compared with unpulsed or irrelevant mouse IgG2b-pulsed DCs). Similar results were also obtained with CFSE dilution assay to measure T-cell proliferation (Fig. 2B) We obtained similar results by using Annexin V-binding assay. As shown in Fig. 3B , co-culture of the CTL and Th1 clones with PKH26-prelabeled 5TGM1 myeloma cells (to identify and gate on myeloma cells) resulted in high percentages of apoptotic (Annexin-V + ) 5TGM1 cells (P < 0.01, compared with 5TGM1 alone or 5TGM1 co-cultured with naïve CD8 + and CD4 + T cells). Coculture with the Th2 clones or with purified CD4 + or CD8 + T cells from naïve mice did not increase the percentages of apoptotic 5TGM1 cells. Fig. 3C shows the pooled data of T cell-induced apoptosis in the myeloma cells.
These results were confirmed with other T-cell clones of CTL, Th1 and Th2 cells (data not shown). These findings indicate that both Id-specific CTL and Interestingly, 5TGM1 myeloma cells expressed Fas molecules (Fig. 4B) .
MHC restriction of T cell-mediated cytotoxic activity
To determine whether the cytotoxic activity of the CTL or (Fig. 4D, surface) . However, intracellular MHC class II molecules could be detected in the myeloma cells (Fig. 4D, cytoplasm) . 
Suppressive activity of the T-cell clones against myeloma cells
In vivo effect of the T-cell clones on myeloma cell growth
To evaluate the in vivo effects of the T-cell clones on myeloma growth and survival, adoptive transfer experiments were performed. Mice were first injected with 5TGM1 cells to establish myeloma, and one week later, a small 
DISSCUSSION
The 5TGM1 murine myeloma model (22) 
